Annapolis Financial Services’s Quest Diagnostics DGX Stock Holding History

Annapolis Financial Services’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-195	Closed	-$26.9K	–	390
2023 Q4	$26.9K	Buy	195 +42	+27%	+$5.52K	0.01%	258
2023 Q3	$18.6K	Sell	153 -263	-63%	-$35K	0.01%	272
2023 Q2	$58.5K	Sell	416 -191	-31%	-$26.3K	0.02%	174
2023 Q1	$85.9K	Sell	607 -47	-7%	-$6.72K	0.03%	145
2022 Q4	$102K	Sell	654 -156	-19%	-$22.4K	0.03%	138
2022 Q3	$99K	Sell	810 -25	-3%	-$3.29K	0.04%	140
2022 Q2	$111K	Hold	835	–	–	0.04%	134
2022 Q1	$114K	Hold	835	–	–	0.04%	136
2021 Q4	$144K	Hold	835	–	–	0.04%	127
2021 Q3	$121K	Hold	835	–	–	0.04%	126
2021 Q2	$110K	Sell	835 -210	-20%	-$27.5K	0.04%	126
2021 Q1	$134K	Sell	1,045 -87	-8%	-$10.7K	0.05%	107
2020 Q4	$135K	Buy	+1,132	New	+$138K	0.05%	101

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Annapolis Financial Services's DGX Position: Q1 2024 in Review

Annapolis Financial Services sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 195 shares — an estimated $26.9K sold.

Annapolis Financial Services first reported a position in DGX in Q4 2020 and held it in 13 quarters. The position peaked at $144K in Q4 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

Annapolis Financial Services reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
Annapolis Financial Services sold 195 Quest Diagnostics shares in Q1 2024, an estimated $26.9K.
Annapolis Financial Services first reported a position in Quest Diagnostics in Q4 2020 and held it in 13 quarters.
Annapolis Financial Services's Quest Diagnostics position peaked at $144K in Q4 2021.
819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Annapolis Financial Services's 13F filing for Q1 2024, filed 17 Apr 2024.